Baxter International Inc.

NYSE:BAX Stock Report

Market Cap: US$14.8b

Baxter International Past Earnings Performance

Past criteria checks 2/6

Baxter International's earnings have been declining at an average annual rate of -43.3%, while the Medical Equipment industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 5.9% per year. Baxter International's return on equity is 1.6%, and it has net margins of 0.8%.

Key information

-43.3%

Earnings growth rate

-43.1%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate5.9%
Return on equity1.6%
Net Margin0.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?

Sep 05
Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?

Baxter- Reiterating Our Buy Rating After A Promising Q2

Aug 07

Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29

Aug 07
Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29

Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Jul 23
Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Baxter: Why Investors Should Take Advantage Of The Low Valuation

Jul 16

Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues

Jul 12
Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues

Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

May 30
Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

May 14
Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible Spinoff

May 08

Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal

Apr 14
Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal

Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts

Feb 23

Baxter International's (NYSE:BAX) Dividend Will Be $0.29

Feb 20
Baxter International's (NYSE:BAX) Dividend Will Be $0.29

Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden

Jan 28
Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden

Baxter International (NYSE:BAX) Could Be Struggling To Allocate Capital

Jan 12
Baxter International (NYSE:BAX) Could Be Struggling To Allocate Capital

Baxter International Inc.'s (NYSE:BAX) Prospects Need A Boost To Lift Shares

Dec 28
Baxter International Inc.'s (NYSE:BAX) Prospects Need A Boost To Lift Shares

Baxter International: A Cheap Big Pharma Stock With Improving Earnings And +3% Dividend Yield

Dec 12

Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?

Oct 12

Dividend Challengers Review: Baxter International

Aug 14

Baxter International: Hillrom Acquisition Could Be A Tailwind For FCF

Jun 12

Revenue & Expenses Breakdown

How Baxter International makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:BAX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2415,0621213,523653
30 Jun 2414,962983,487653
31 Mar 2414,892-383,512658
31 Dec 2314,813-763,495655
30 Sep 2311,379962,907537
30 Jun 2312,389-2,9323,103555
31 Mar 2314,461-2,6733,489608
31 Dec 2214,506-2,6663,550599
30 Sep 2214,275-2,5683,435580
30 Jun 2213,8928763,212562
31 Mar 2213,3969922,957553
31 Dec 2112,1461,0222,605530
30 Sep 2112,4511,2142,530528
30 Jun 2112,1971,1202,460521
31 Mar 2111,8171,0682,370499
31 Dec 2011,6731,1022,405519
30 Sep 2011,5319112,360516
30 Jun 2011,4109242,383528
31 Mar 2011,5269912,414552
31 Dec 1911,3621,0012,442561
30 Sep 1911,1561,3352,348554
30 Jun 1911,0661,4842,359573
31 Mar 1911,0601,5052,399595
31 Dec 1811,0991,5522,401618
30 Sep 1811,0631,0652,527636
30 Jun 1811,0097952,572632
31 Mar 1810,7638402,478621
31 Dec 1710,5846092,516615
30 Sep 1710,4321,0252,424584
30 Jun 1710,2839042,382564
31 Mar 1710,2631,8522,447560
31 Dec 1610,1634,9662,520566
30 Sep 1610,1214,9092,566573
30 Jun 1610,0504,7842,625584
31 Mar 169,9403,6462,704582
31 Dec 159,9683932,832589
30 Sep 1510,1543372,972585
30 Jun 1510,3765103,087593
31 Mar 159,274843,037473
31 Dec 1410,7194573,182608
30 Sep 1412,2527393,301743
30 Jun 1413,2531,0923,334847
31 Mar 1415,3671,9673,4371,047
31 Dec 139,4133152,859534

Quality Earnings: BAX has a large one-off loss of $1.0B impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: BAX's current net profit margins (0.8%) are lower than last year (0.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: BAX's earnings have declined by 43.3% per year over the past 5 years.

Accelerating Growth: BAX's earnings growth over the past year (26%) exceeds its 5-year average (-43.3% per year).

Earnings vs Industry: BAX earnings growth over the past year (26%) exceeded the Medical Equipment industry 15%.

Return on Equity

High ROE: BAX's Return on Equity (1.6%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 23:09
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Baxter International Inc. is covered by 46 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Benjamin YeohAtlantic Equities LLP
Daniel OwczarskiAvondale Partners